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Summary
A case of hypertension in a young woman caused
by an extra-adrenal phaeochromocytoma (EAP)
situated in the hilum of the left kidney is reported.
Surgical removal of the EAP resulted in control of
the patient's hypertension without further drug treat-
ment The clinical features. diagnostic work-up and
management of EAP are briefly discussed.
S Air AIecI J 1986; 69: 143 - 144.
Phaeochromocytoma is a rare tumour with a reported incidence
of 1 in 50000 of the adult populationI and 1 - 10/1 000 of
hypertensive patients. 2 It has been called the '10% tumour'
since approximately 10% are malignant, 10% bilateral and 10%
extra-adrenal.3 Thus, the calculated incidence of extra-adrenal
phaeochromocytoma (EAP) is 1 in 500 000 of the adult popula-
tion.
Sustained hypertension is found in 50% of patients with
phaeochromocytoma and paroxysmal hypertension in the other
50%.4 Headache, sweating and palpitations are features of the
condition in 60 - 80% of the cases, and less than 50% of
patients are ihin.5
According to Fries el al. ,6 EAP is found in the neck in 2% of
cases, the thorax in 12%, the upper abdomen in 43%, the lower
abdomen in 29%, the urinary bladder in 12%, and the pelvis in
2%.
The conditions which have been reported to be associated
with phaeochromocytoma include the neuro-ectodermal
syndromes (von Hippel-Lindau disease, Sturge-Weber
syndrome, tuberous sclerosis), renal cell carcinoma,
cholelithiasis, congenital heart disease, aganglionic megacolon
and mega-ureter.4,6-9 There is, however, no association between
EAP and the type II multiple endocrine adenopathy
syndrome. IQ
Malignant change in EAP is reported in one series to be
22% and has a uniformly dismal prognosis, except for cases of
vesical neoplasms in which the outlook is bener.9 At present
treatment with iodine-l31 meta-iodobenzylguanidine (MIBG)
offers some hope of achieving a cure in malignant phaeochromo-
cytomas. 1I
Case report
A 19-year-old non-pregnant coloured woman complained of head-
aches, sweating and episodes of syncope. She was of slender build
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with a blood pressure of 160/110 mmHg, but the rest of the
physical examination was unremarkable. The hypertension was
controlled on treatment with labetalol and prazosin.
The patient's full blood count, serum urea, creatinine and
electrolyte levels, fasting blood sugar, chest and abdominal radio-
graphs and electrocardiogram were normal.
An ultrasound examination revealed normal kidneys and a 2 x 3
cm weLl-eircumscribed mass with a mixed echoic pattern in the
hilum of the left kidney. The excretory urogram was normal.
Renal arteriography (Fig. 1) demonstrated a distinct tumour blush
in the hilum of the left kidney. The lesion was also clearly
delineated on computed tomography (CT) (Fig. 2). Six-hourly
urinary vanillylmandelic acid (VMA) estimations revealed values
of 3,8, 3,3, 6,5 and 3,2 Jlmol VMA/mmol urinary creatinine
(normal < 3,0). Phenoxybenzamine was added to the patient's
treatment regimen, and I week later a thoraco-abdominal explora-
tion was carried out. The left kidney and adrenal gland were
normal. The tumour in the left renal hilum was enmeshed in a
rich vasculature, but with careful dissection was removed com-
pletely without compromising the left renal vessels. There was no
direct communication between the tumour and the sympathetic
trunk or adrenal gland. No other tumours were palpable in the left
retroperitoneal region.
The patient's postoperative course was uneventful and at 15
months follow-up she was without symptoms and normotensive.
A I3II-MIBG scan was performed I month postoperatively, since
this investigation only became available at our institution at that
time. No residual foci of phaeochromocytoma could be demon-
strated.
Histological study of the tumour confirmed the diagnosis of
phaeochromocytoma.
Fig. 1. Arteriogram of the left kidney.
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Fig. 2. eT of the lesion in hilum of the left kidney.
Discussion
Because of its protean manifestations, the diagnosis of phaeo-
chromocytoma is easily missed. However, recent data indicate
that a complete history alone can result in the diagnosis in
nearly 95% of positive cases and can virtually exclude the
condition in 99% of negative cases.4 The simplest screening
test for phaeochromocytoma is determination of the urinary
metanephrine value, with a 95% sensitivity and 97% specificity.
This test is less subject to drug and diet interference than
VMA determinations. Fractionated serum catecholamine deter-
mination is reported to be virtually 100% diagnostic, but the
results need to be interpreted with care because of patients'
stress responses. 12
Localization of a phaeochromocytoma can be difficult and
hazardous if invasive procedures such as angiography and
catheterization of the vena cava are used. eT, however, will
localize more than 90% of tumours and has a resolution of
approximately 2 cm. l3
In a series of 8 cases,14 the MIBG scan was highly accurate,
with a specificity of 100%. Tumours as small as 0,2 g were
consistently localized but administration of reserpine and tri-
cyclic antidepressants may interfere with the scan.
Although Ct- and ,B-adrenergic blocking agents are advocated
for the pre-operative control of catecholamine effects, Stewart'
has reported a series of 80 cases of phaeochromocytomas
which were operated on successfully without the use of pre-
operative adrenergic blockers. These patients received a trans-
fusion of 2 units of blood on the day before operation and no
intra-operative mortality was recorded.
At present the customary laborious and expensive work-up
on .patients with suspected phaeochromocytoma can be
obviated, and a high degree of accuracy in diagnosis and
localization may be achieved. With CT and MIBG scan on an
outpatient protocol the cost of pre-operative studies can be
reduced more than tenfold.4
The result of surgical extirpation of benign phaeochromo-
cytomas is good, provided all the tumour is completely
removed. Postoperative normotension is achieved in 67% of
patients with sustained and in 95% of patients with paroxysmal
hypertension pre-operatively. However, a peri-operative mor-
tality rate of 3,8% has been recorded. I
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